WallStreetZenWallStreetZen

NASDAQ: APGN
Apexigen Inc Stock

Open Broker Account
$4.12-0.92 (-18.25%)
Updated Sep 23, 2022
APGN Price
$4.12
Fair Value Price
N/A
Market Cap
$88.37M
52 Week Low
$3.67
52 Week High
$31.35
P/E
-2.94x
P/B
-19.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$39.18M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.04
Operating Cash Flow
-$24M
Beta
0.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how APGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

APGN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
APGN is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
APGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more APGN due diligence checks available for Premium users.

Be the first to know about important APGN news, forecast changes, insider trades & much more!

APGN News

Valuation

APGN fair value

Fair Value of APGN stock based on Discounted Cash Flow (DCF)
Price
$4.12
Fair Value
$22.72
Undervalued by
81.87%
APGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

APGN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.94x
Industry
15.88x
Market
27.65x

APGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-19.1x
Industry
4.31x

APGN's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.7M
Profit Margin
0%
APGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$51.8M
Liabilities
$4.8M
Debt to equity
-1.04
APGN's short-term liabilities ($4.82M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
APGN's short-term assets ($120.02k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
APGN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
APGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$7.9M
Investing
$3.9M
Financing
-$6.1M
APGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

APGN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
APGN$88.37M-18.25%-2.94x-19.10x
DARE$88.21M-1.89%-2.26x2.67x
GNTA$88.53M-2.61%-12.09x2.10x
FIXX$88.97M-6.06%-51.67x0.37x
PDSB$86.51M-4.70%-3.07x1.68x

Apexigen Stock FAQ

What is Apexigen's quote symbol?

NASDAQ: APGN) Apexigen trades on the NASDAQ under the ticker symbol APGN. Apexigen stock quotes can also be displayed as NASDAQ: APGN.

If you're new to stock investing, here's how to buy Apexigen stock.

What is the 52 week high and low for Apexigen (NASDAQ: APGN)?

(NASDAQ: APGN) Apexigen's 52-week high was $31.35, and its 52-week low was $3.67. It is currently -86.86% from its 52-week high and 12.26% from its 52-week low.

How much is Apexigen stock worth today?

(NASDAQ: APGN) Apexigen currently has 21,448,663 outstanding shares. With Apexigen stock trading at $4.12 per share, the total value of Apexigen stock (market capitalization) is $88.37M.

Apexigen stock was originally listed at a price of $10.23 in Jan 29, 2021. If you had invested in Apexigen stock at $10.23, your return over the last 1 years would have been -59.73%, for an annualized return of -59.73% (not including any dividends or dividend reinvestments).

How much is Apexigen's stock price per share?

(NASDAQ: APGN) Apexigen stock price per share is $4.12 today (as of Sep 23, 2022).

What is Apexigen's Market Cap?

(NASDAQ: APGN) Apexigen's market cap is $88.37M, as of Sep 27, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Apexigen's market cap is calculated by multiplying APGN's current stock price of $4.12 by APGN's total outstanding shares of 21,448,663.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.